Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growthNingning Liu, Jinbao Liu|Oncotarget|2014Cited by 170
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptorYuning Liao, Jinbao Liu|Cell Death and Disease|2017Cited by 118
USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemiaYuning Liao, Jinbao Liu|Cell Discovery|2019Cited by 97
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancerLu Xiao, Jinbao Liu|Cell Death and Disease|2017Cited by 97
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanismsXin Chen, Jinbao Liu|Oncotarget|2014Cited by 80